| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 10/30/2013 | EP2655358A1 Oxindolopyrimidine as igf1r receptor inhibitors |
| 10/30/2013 | EP2655355A1 New triazolylphenyl sulfonamides as serine/threonine kinase inhibitors |
| 10/30/2013 | EP2655350A1 Bicyclic pkm2 activators |
| 10/30/2013 | EP2655345A1 Aryl triazole compounds with antitumoural activity |
| 10/30/2013 | EP2655344A1 Novel phenazine derivatives and their use |
| 10/30/2013 | EP2655340A1 Bi-heteroaryl compounds as vps34 inhibitors |
| 10/30/2013 | EP2655323A1 Ingenol-3-acylates iii and ingenol-3-carbamates |
| 10/30/2013 | EP2655312A1 3-acyl-ingenols ii |
| 10/30/2013 | EP2655311A1 Ingenol-3-acylates i |
| 10/30/2013 | EP2655309A1 Methods and compositions for treating lung cancer |
| 10/30/2013 | EP2654801A1 Targeting glioma stem cells by sequence-specific functional inhibition of pro-survival oncomir-138 |
| 10/30/2013 | EP2654799A1 Polymer-sunitinib conjugates |
| 10/30/2013 | EP2654797A1 Polymer-des-ethyl sunitinib conjugates |
| 10/30/2013 | EP2654796A1 Agents for clearing biomolecules from circulation |
| 10/30/2013 | EP2654795A1 Multi-arm polymeric prodrug conjugates of pemetrexed-based compounds |
| 10/30/2013 | EP2654789A1 Antibodies against human cd39 and use thereof |
| 10/30/2013 | EP2654776A1 Use of pegylated recombinant human arginase for treatment of leukemia |
| 10/30/2013 | EP2654754A2 Combination |
| 10/30/2013 | EP2654748A1 Indazole derivatives useful as erk inhibitors |
| 10/30/2013 | EP2654736A2 Novel pharmaceutical composition |
| 10/30/2013 | CN103380214A Inhibitors of branched-chain-aminotransferase-1 (BCAT1) for the treatment of brain tumors |
| 10/30/2013 | CN103380117A Picolinamide inhibitors of kinases |
| 10/30/2013 | CN103379914A Method for treating breast cancer by decreasing the expression of adenine nucleotide translocator 2 mRNA |
| 10/30/2013 | CN103374576A Cancer antigen-specific t-cell receptor gene, peptide encoded by the gene, and use of them |
| 10/30/2013 | CN103374573A Hepatoma cell aptamer sequence and application thereof |
| 10/30/2013 | CN103374572A Sequence of aptamer of hepatoma cell and application thereof |
| 10/30/2013 | CN103374538A Derivative bacterial strain composition containing clostridium ghonii strains and method for using same |
| 10/30/2013 | CN103374128A Amphiphilic triblock copolymer, polymer nano-carrier preparation and preparation methods |
| 10/30/2013 | CN103374078A Homopolysaccharide in ganoderma sinensis submerged fermentation mycelium, as well as preparation method and applications thereof |
| 10/30/2013 | CN103374074A Anti-CD25 single-chain antibody |
| 10/30/2013 | CN103374073A Human derived monoclonal antibody for identifying activated integrin alpha 4 beta 7 |
| 10/30/2013 | CN103374072A Preparation of anti-Mac-2BP humanized antibody |
| 10/30/2013 | CN103374071A Preparation of anti-DERLIN-1 humanized antibody |
| 10/30/2013 | CN103374066A Alpha B-O-conotoxin and medicine composition and application thereof |
| 10/30/2013 | CN103374056A 1-Acetyl-beta-carboline-3-formyl amino-acid benzyl ester, and synthesis and application thereof |
| 10/30/2013 | CN103374042A Dynamic anti-cancer platinum compound with two different ligands at syn-position |
| 10/30/2013 | CN103374021A Zinc binding group containing pyridopyrimidin inhibitor for HDAC (Histone Deacetylase) and mTOR (Mammalian Target of Rapamycin) |
| 10/30/2013 | CN103374020A Naphthalene-ring containing thiazole [4, 5-b] quinoxaline derivatives and preparation methods thereof |
| 10/30/2013 | CN103374015A Camptothecin derivative and preparation method thereof as well as application of camptothecin derivative in preparation of medicine for treating tumours |
| 10/30/2013 | CN103374001A Imidazo triazines mTOR (Mammalian Target of Rapamycin) inhibitor |
| 10/30/2013 | CN103374000A Pyrimido diazepine compound as well as pharmaceutical composition and application thereof |
| 10/30/2013 | CN103373997A Zinc binding group containing pyridonaphthyridine inhibitor for HDAC (Histone Deacetylase) and mTOR (Mammalian Target of Rapamycin) |
| 10/30/2013 | CN103373996A Bicyclic derivatives serving as CRTH2 receptor antagonist |
| 10/30/2013 | CN103373994A Therapeutic compounds |
| 10/30/2013 | CN103373992A 1, 3, 4-Oxadiazole and pyridine (pyrazine) ring-containing acylhydrazone derivatives, preparation method and applications |
| 10/30/2013 | CN103373988A 1, 2, 4-Triazole and pyrazine ring-containing acylhydrazone derivatives, preparation method and applications |
| 10/30/2013 | CN103373986A Crizotinib prodrug, as well as preparation and application thereof |
| 10/30/2013 | CN103373984A Hydrindene amide compound crystal form, preparation method and usage thereof |
| 10/30/2013 | CN103373981A Application of oxygen heterocycle containing sulfanilamide derivative |
| 10/30/2013 | CN103373971A Urea compounds serving as protein kinase inhibitors |
| 10/30/2013 | CN103373969A Phenyl imidazole ring-substituted amide compounds as well as preparation method and application for same |
| 10/30/2013 | CN103373966A 4-anilino quinazoline amido derivatives as well as preparation methods and applications thereof |
| 10/30/2013 | CN103373961A Preparation of (1, 3-diphenyl-1hydrogen-4-pyrazolyl) methyl benzoic acid serial compounds and applications in treatment of melanoma |
| 10/30/2013 | CN103373907A Biphenol compound with anti-tumor activity and pharmaceutical use of compound |
| 10/30/2013 | CN103373906A 2,4'-biphenol compound with angiogenesis inhibiting effect and pharmaceutica use thereof |
| 10/30/2013 | CN103372220A Pharmaceutical microsphere for embolization |
| 10/30/2013 | CN103372213A Application of inhibitors of phospholipid scramblases (plscrs) for preparing medicine for the prophylactic or therapeutic treatment of cancers |
| 10/30/2013 | CN103372212A Quinazoline molecular targeted medicinal composition |
| 10/30/2013 | CN103372210A Application of berberine combined chemotherapeutic medicament in antitumor therapy |
| 10/30/2013 | CN103372209A Application of antibody of gp96 protein in preparation of cancer cell inhibitor |
| 10/30/2013 | CN103372205A Preparation method of tumor dendritic cell vaccine sensitized by glycosylated MUC1 (mucoprotein 1) antigen |
| 10/30/2013 | CN103372204A External xenoliths vaccine combined dendritic cell cytokine induced killer (DC-CIK) new technology for cancer therapy |
| 10/30/2013 | CN103372203A Antigen composition, preparation method and application of antigen composition and tumour vaccine |
| 10/30/2013 | CN103372202A Lactoprotein/fatty acid-containing composition, and preparation method and application thereof |
| 10/30/2013 | CN103372195A Medicament for treating cancer |
| 10/30/2013 | CN103372171A Potent anti-cancer liquid for external use and preparation method thereof |
| 10/30/2013 | CN103372151A Traditional Chinese medicine preparation for treating breast cancer and lymph cancer |
| 10/30/2013 | CN103372137A Traditional Chinese medicine preparation for treating lung tumor and lung cancer of human body |
| 10/30/2013 | CN103372102A Pure traditional Chinese medicine for treating breast cancers by methods of inhaling and detoxifying through sweating |
| 10/30/2013 | CN103372101A Pure traditional Chinese medicine for treating tumors by methods of snorting and detoxifying through sweating |
| 10/30/2013 | CN103372100A Traditional Chinese medicine for treating tumors by treatment methods of snorting and fumigating |
| 10/30/2013 | CN103372070A Medicine for treating tumors by methods of smelling and detoxifying through sweating |
| 10/30/2013 | CN103372069A Traditional Chinese medicine for treating tumors by methods of smelling and sweating |
| 10/30/2013 | CN103372059A Extraction process of lotus seedpod polyphenols |
| 10/30/2013 | CN103372036A Preparation method of pomegranate leaf tannin |
| 10/30/2013 | CN103372029A NK (Natural Killer) cell new technology for treating tumor |
| 10/30/2013 | CN103372012A Application of theanine and like in preparation of product for preventing and treating disease such as cancers |
| 10/30/2013 | CN103371996A Application of Sarcaboside A in medicine for treating nasopharynx cancer |
| 10/30/2013 | CN103371995A Application of arctigenin in preparation of tumor immunology enhancer |
| 10/30/2013 | CN103371994A Medicine for treating melanoma and application thereof |
| 10/30/2013 | CN103371992A Application of (E)-nitrogen-(4-cinnamamide butyl)benzamide in preparing anti-tumor medicaments |
| 10/30/2013 | CN103371991A Application of dimethyldiguanide in preparation of medicaments for preventing or treating hepatocellular carcinoma |
| 10/30/2013 | CN103371990A Application of dryopterisfragrans element of dryopterisfragrans in preparation of antineoplastic medicaments |
| 10/30/2013 | CN103371989A Application of xanthohumol in preparation of medicine used for preventing and/or treating differentiation and bone resorption of osteoclast |
| 10/30/2013 | CN103371980A Dexamethasone sodium phosphate freeze-dried powder injection |
| 10/30/2013 | CN103371975A Targeted long-circulation liposome preparation and preparation method thereof |
| 10/30/2013 | CN103371974A Drug sustained release polymeric microspheres prepared based on micro-fluidic technology and application |
| 10/30/2013 | CN103371972A Andrographolide suspension and preparation method and medical application thereof |
| 10/30/2013 | CN102924600B Death receptor-5 agitated polyvalent antibody and application thereof in preparation of anti-tumor medicines |
| 10/30/2013 | CN102697759B Application of N,N'-double (4-hydroxyl salicylidene)- o-phenylenediamine in preparation of pharmaceutical for treating melanin tumors |
| 10/30/2013 | CN102670578B Application of protosappanin B in preparation of bladder cancer resistant perfusion fluid |
| 10/30/2013 | CN102657674B Application of Trichoderma pseudokoningii extracellular polysaccharides having anticancer activities |
| 10/30/2013 | CN102631682B Graphene oxide and sanguinarine compound and preparation method thereof |
| 10/30/2013 | CN102614183B Oral preparation containing tegafur, gimeracil and oteracil potassium |
| 10/30/2013 | CN102552897B Prophylactic VLP (Virus-like Particle) vaccine for cervical carcinoma |
| 10/30/2013 | CN102552239B Method for preparing anti-inflammatory and anti-tumor active ingredient group from liquorice dregs and application thereof |
| 10/30/2013 | CN102552150B Preparation and application of geldanamycin liposome |
| 10/30/2013 | CN102526626B Medicament for treating esophagus cancer and preparation method thereof |
| 10/30/2013 | CN102512546B Traditional Chinese medicine used for esophageal cancer patients refusing surgery |
| 10/30/2013 | CN102464725B Gastrodia elata BL. polysaccharide and degradation products thereof and preparation methods and applications of degradation products |